| Bioactivity | 2’,3’-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2’,3’-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine |
| CAS | 2305415-94-3 |
| Formula | C22H42N2O7Si2 |
| Molar Mass | 502.75 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
2’,3’-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine
CAS: 2305415-94-3 F: C22H42N2O7Si2 W: 502.75
2’,3’-Bis(O-(t-butyldimethylsilyl)-5-methoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broa
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.